leaders. This finding, combined with the outpouring of positive feedback about the exhibition 4 led to the commissioning of an RCP fellowship programme, the Estelle Wolfson Emerging Women Leaders Programme, among the new consultant workforce. The emphasis is on mentoring and protected leadership development and networking opportunities for aspiring female leaders.Here we have considered different strategies the RCP has employed to recognise women in medicine and widen access to leadership opportunities. By recognising women in medicine through the exhibition and widening access to leadership opportunities through the Estelle Wolfson Emerging Women Leaders Programme, the RCP is showing its commitment to representative and effective medical leadership.In 2017, Mark Porter 5 stated "It's about challenging the structures that entrench inequality, but also about challenging our own behaviour and attitudes, and those we experience every day. Until we are truly equal, we are all diminished". The RCP, through the initiatives described, has tried to address the challenge identified by Porter.We declare no comepting interests. Lady Estelle Wolfson, patron of the Estelle Wolfson Emerging Women Leaders Programme at the Royal College of Physicians, helped fund the programme.

No abstract

No abstract

To highlight and celebrate the role of women in medicine in 2017, the first year in history that women outnumbered men in leading the British and Irish medical royal colleges.

sex and/or receptive anal sex. These swabs are analysed using the Aptima Combo II platform, for Neisseria gonorrhoea (GC). Aim(s)/objectives With analysis costing £6.20 per swab we sought to explore cost effectiveness, review culture results and partner notification results. Methods Inclusion criteria were heterosexual patients with exclusively extra-genital GC who did not present as a contact of GC. We performed a retrospective case note review of 54 sets of notes asserting symptom history, concurrent STI diagnosis, culture results and any positive contacts.Results Over the year, a total of 13123 throat swabs were sent. There were 50 confirmed positive results giving swabs sent per positive result ratio of 262:1, or a cost of £1624.40 per positive result. For rectal swabs; a total of 1362 were sent. There were 4 positive results (all female) giving swabs sent per positive result ratio of 341:1, or a cost of £2114.20 per positive result. 2% of patients with a positive extra-genital swab result gave a history of throat or rectal symptoms. 18% had a concurrent STI diagnosis, 0% had a positive culture result from the same site. 6% had at least one subsequent positive contact, all of which were pharyngeal positive. Discussion/conclusion Extra-genital testing has detected cases which would otherwise have been missed with purely genital screening. However numbers are too small to advocate a change in practice to routine extra-genital screening in all asymptomatic individuals. P29AUDIT Background Men who have sex with men (MSM) in the UK are at relatively high risk of acquiring new STIs. The British Association of Sexual Health and HIV recommend active recall of MSM diagnosed with sexually transmitted infections (STIs) for retesting after 3 months. Objectives An audit was undertaken to assess the incidence of bacterial STIs, and rates of re-screening and re-infection amongst MSM attending a large genitourinary (GU) outpatient clinic in London. Methods A retrospective audit of GU coding data on MSM attendees aged >18 years between January and December 2014 was performed. Data was collected on patient demographics, STI tests performed and diagnoses. Results 397 MSM were diagnosed with 826 new bacterial STIs during the audit period (762 STIs over 534 episodes occurred in the initial 9 month period). 145 (37%) patients were HIV infected. In 98/534 (18%) episodes, a repeat screen was performed within 3 months (excluding screening within the initial 6 weeks after an STI was diagnosed); in 21 (21%) of these episodes, a further 1 ‡ STI was diagnosed. Overall, the mean time to re-screening during the study period was 108 days (excluding initial 6 weeks; range 43-282). In 149/534 (28%) of STI episodes, no repeat STI screen was performed within the period analysed. Conclusion The incidence of STIs and re-infection in this high risk group is high, however prompt re-screening rates are low, highlighting the need for active recall. Routine 3 month text recall of MSM with an STI has since been implemented. Background The prevalence o...